Live Breaking News & Updates on New Indication Alert

Stay updated with breaking news from New indication alert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pearce IP BioBlast w/e 17 May 2024

Pearce IP BioBlast w/e 17 May 2024
lexology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lexology.com Daily Mail and Mail on Sunday newspapers.

West Virginia , United States , Saudi Arabia , South Korea , United Kingdom , Samsung Bioepis , Alexion Soliris , Klinge Pharma Gmb , Glenmark Lirafit , Pharma Klinge , Mylan Biocon , Samsung Bioepi , Liraglutide Biosimilar , Aflibercept Biosimilar , Formycon Ravegza , Novo Holdings , Danaher Corporation , Eu Committee For Medicinal Products , Hamburg Local Division , Korea Ministry Of Food , Quallent Pharmaceuticals , Cardior Pharmaceuticals , European Union , United States District Court , International Recognition Procedure , Us District Court ,

Pearce IP BioBlast w/e 22 March 2024

On 22 March 2024, the first case management hearing was held before Justice Nicholas in the Federal Court of Australia, Sydney, in proceedings… ....

South Korea , United States , United Kingdom , New South Wales , Samsung Bioepis , Genentech Avastin , Novo Nordisk Awiqli , Novarti Xolair , Celltrion Omalizumab Biosimilars , Celltrion Omlyclo , Ustekinumab Biosimilar , Justice Nicholas , Fresenius Kabi , Sandoz Denosumab , Janssen Stelara , Australian Court , Novo Holdings Nordisk , China Daily , European Union , European Medicines Agency , Committee For Medicinal Products Human Use , Bio Thera Solutions Partners , European Commission , Novo Nordisk , Bio Thera Solutions , Samsung Bioepis Seeks ,

Pearce IP BioBlast w/e 26 Jan 2024

AbbVie announced it will invest US$233M in its biologics manufacturing facility in Singapore. The investment will add 24,000L of biologics… ....

United Kingdom , South Korea , United States , Bayer Eylea , Samsung Biologics , Genentech Avastin , Samsung Bioepi Onbevzi , Coheru Cimerli , Alexion Soliris , Genentech Lucentis , Samsung Bioepis , Ranibizumab Biosimilar , Regeneron Sanofi Dupixent , Samsung Bioepi Episcli , Coherus Bioscience Cimerli , Chinese National Medical Products Administration , European Commission , Us District Court , Regulatory Agency , Korean Ministry Of Food , Therapeutic Goods Administration , Expand Biologics Manufacturing Facility , New Indication Alert , Treat Eoe , Children One Year , Samsung Bioepis Surpasses ,

BioBlast w/e 15 Dec 23

Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug… ....

South Korea , Lendava Lendva , Samsung Biologics , Biomed Nona Biosciences , Nona Biosciences , Genentech Avastin , Seagen Astella Padcev , Celltrion Vegzelma , Genentech Actemra , Abbvie Humira , Korea Ministry Of Food , Intas Pharmaceuticals , Korean Ministry Of Food , Japan National Health Insurance , Approval Alert , Korean Ministry , Drug Safety , New Indication Alert , Plus Padcev , Urothelial Cancer , Astella Padcev , Biologics License Application , Positive Metastatic Breast , Biomedical Reviewreported , Harbour Biomed , Nona Biosciences Inks ,

BioBlast w/e 17 Nov 23

AstraZeneca (AZ) announced the FDA approved its Truqap® (capivasertib) in combination with Faslodex (fulvestrant) for the treatment of adult patients… ....

Abbvie Humira , Samsung Bioepis , Merck Keytruda , Abbvie Skyrizi , Roche Tecentriq , Bristol Myers Squibb , Health Canada Approves Alvotech , European Commission , Health Canada , China National Medical Products Administration , Korean Ministry Of Food , Ministry Of Food , French Parliament , European Medicines Agency , Approval Alert , Treat Advanced , New Indication Alert , Treat Chron , Korean Ministry , Drug Safety , French Parliament Considers Reform , Enable Biosimilar Substitution , Social Security Financing Bill , Agence Nationale , European Medicines Agency April , Myers Squibb ,